Tag: interest

STOCKHOLM, June 07, 2025 (GLOBE NEWSWIRE) -- "Nihao! China" Dragon Boat Festival Garden Party jointly held by China Cultural Center in Stockholm and Culture and Tourism Department of Guizhou Province, successfully concluded at Kungsträdgården, Stockholm, Sweden on May 31st (local time in Sweden). To celebrate the 75th anniversary of the establishment of diplomatic relations between China and Sweden, the Guizhou delegation, who came from afar, includes inheritors of intangible cultural heritage and song and dance troupes, meticulously prepared four immersive cultural experience zones: “Tea for Harmony Yaji Cultural Salon”, “Wonder on Fingertips, Great Beauty of Intangible Heritage”, “Delicious Cuisine in Duanwu, Happy Journey to Explore” and “Gorgeous Ethic Costumes, Beauty and Co-Prosperity”. Distinctive ethnic songs and dances of Guizhou dazzled the audience during the “Conversation and Connection” performance, presenting the unique charm of the “Fascinating Guizhou, A Heaven of Myriad Mountains” in a panoramic way to the Nordic audience, giving a heartfelt cultural tribute to the friendship between China and Sweden.

LEEDS, United Kingdom, June 07, 2025 (GLOBE NEWSWIRE) -- Nimanode, a pioneering protocol building AI-driven autonomous agents on the XRP Ledger (XRPL), has officially launched the presale of its native utility token, $NMA. As the first no-code AI agent builder on XRPL, Nimanode empowers users to deploy, customize, and manage intelligent blockchain agents without writing a single line of code.

Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor

U.S.-Based Supplement Company Integrates Findings from 230+ Scientific Studies to Guide Transparent Wellness Formulations

SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma’s registration statement issued in connection with Zenas BioPharma’s initial public offering (the “IPO”) held on or around September 13, 2024, and were damaged thereby, have until June 16, 2025 to seek appointment as lead plaintiff of the Zenas BioPharma class action lawsuit. Captioned Buathongsri v. Zenas BioPharma, Inc., No. 25-cv-10988 (D. Mass.), the Zenas BioPharma class action lawsuit charges Zenas BioPharma as well as certain of Zenas BioPharma’s top executives and directors, as well as the underwriters of the IPO, with violations of the Securities Act of 1933.

Plant-Based Supplement Includes Five Individual Ingredients Studied for Their Role in Supporting Memory and Focus

SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving EchoStar Corporation (NASDAQ: SATS) focused on whether EchoStar and certain of its executives made false and/or misleading statements and/or failed to disclose material information to investors.

SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN) (the “Company,” “Opendoor,” “we,” “our” or “us”), a leading e-commerce platform for residential real estate transactions, filed a preliminary proxy statement. The proxy statement was furnished in connection with the solicitation of proxies by Opendoor’s Board of Directors (the “Board”) for use at the Company’s Special Meeting of Stockholders to be held on Monday, July 28, 2025, at 9:30 a.m. Pacific Time.

VANCOUVER, British Columbia, June 06, 2025 (GLOBE NEWSWIRE) --  Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the closing of its previously announced non-brokered private placement for gross proceeds of $4,905,150 - consisting of $3,555,150 of Units and $1,350,000 of Debenture Units (each as defined below).